Trump and Merck Strike Deal to Slash IVF Drug Costs
The White House and Merck KGaA announced an agreement Thursday aimed at dramatically reducing prices for in vitro fertilization (IVF) medications in the U.S. The effort is part of a broader push to make fertility treatment more affordable and accessible. Under the deal, Merck — via its U.S. arm EMD Serono — will offer key…